Inventor
LULY JAY R
US59 patents
⚠️ This page may combine multiple inventors who share the name “LULY JAY R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
36 patentsUS4977277ADec 11, 1990
Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof
ABBOTT LAB165 citations99
US5527907AJun 18, 1996
Macrolide immunomodulators
ABBOTT LAB165 citations98
US5457111AOct 10, 1995
Macrocyclic immunomodulators
ABBOTT LAB160 citations97
US5672605ASep 30, 1997
Macrolide immunomodulators
ABBOTT LAB69 citations96
US5583139ADec 10, 1996
Marcolide immunomodulators
ABBOTT LAB65 citations96
US5032577AJul 16, 1991
Peptidylaminodiols
ABBOTT LAB68 citations96
US4826815AMay 2, 1989
Renin inhibiting compounds
ABBOTT LAB61 citations95
US5604234AFeb 18, 1997
Substituted thiol macrolactam immunomodulators
ABBOTT LAB27 citations93
US5563172AOct 8, 1996
Macrocyclic amide and urea immunomodulators
ABBOTT LAB25 citations93
US5561137AOct 1, 1996
Thio-heterocyclic macrolactam immunomodulators
ABBOTT LAB26 citations93
US5534632AJul 9, 1996
Macrocyclic carbamate immunomodulators
ABBOTT LAB24 citations93
US4725583AFeb 16, 1988
Functionalized peptidylaminoalcohols
ABBOTT LAB27 citations93
US5708002AJan 13, 1998
Macrocyclic immunomodulators
ABBOTT LAB26 citations92
US5612350AMar 18, 1997
Macrocyclic immunomodulators with novel cyclohexyl ring replacements
ABBOTT LAB26 citations92
US5599927AFeb 4, 1997
Macrocyclic immunomodulators with novel cyclohexyl ring replacements
ABBOTT LAB20 citations92
US5541193AJul 30, 1996
Heterocycle-containing macrocyclic immunomodulators
ABBOTT LAB26 citations92
US5541189AJul 30, 1996
Substituted aliphatic amine-containing macrocyclic immunomodulators
ABBOTT LAB23 citations92
US5457194AOct 10, 1995
Substituted aliphatic amine-containing macrocyclic immunomodulators
ABBOTT LAB36 citations92
US6166013ADec 26, 2000
Glucocortiocoid-selective agents
ABBOTT LAB41 citations90
US5561228AOct 1, 1996
Macrocyclic immunomodulators
ABBOTT LAB20 citations84
US4857507AAug 15, 1989
Angiotensinogen analogs
ABBOTT LAB23 citations81
US4680284AJul 14, 1987
Modified phenylalanine peptidylaminodiols
ABBOTT LAB20 citations81
US4645759AFeb 24, 1987
Renin inhibiting compounds
ABBOTT LAB22 citations80
US5731320AMar 24, 1998
Macrocyclic amide and urea immunomodulators
ABBOTT LAB12 citations74
US5663148ASep 2, 1997
Anaphylatoxin receptor ligands containing lipophilic residues
ABBOTT LAB17 citations74
US5643918AJul 1, 1997
Marcrocyclic amide and urea immunomodulators
ABBOTT LAB8 citations74
US5561140AOct 1, 1996
Substituted alicyclic amine-containing macrocyclic immunomodulators
ABBOTT LAB16 citations74
US5561139AOct 1, 1996
Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators
ABBOTT LAB6 citations74
US5530119AJun 25, 1996
Substituted alicyclic amine-containing macrocyclic immunomodulators
ABBOTT LAB8 citations74
US5530120AJun 25, 1996
Substituted alicyclic aliphatic-amine containing macrocyclic immunomodulators
ABBOTT LAB9 citations74
US5214129AMay 25, 1993
Peptidylaminodiols
ABBOTT LAB9 citations74
US4837204AJun 6, 1989
Functionalized peptidyl aminodiols and -triols
ABBOTT LAB14 citations74
US4725584AFeb 16, 1988
Peptidyl-1-amino-2,4-diols
ABBOTT LAB10 citations74
US5387671AFeb 7, 1995
Hexa- and heptapeptide anaphylatoxin-receptor ligands
ABBOTT LAB10 citations73
US5386011AJan 31, 1995
Hexapeptide anaphylatoxin-receptor ligands
ABBOTT LAB13 citations73
US5190922AMar 2, 1993
Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands
ABBOTT LAB12 citations73
MILLENNIUM PHARM INC
10 patentsUS6613905B1Sep 2, 2003
Chemokine receptor antagonists and methods of use therefor
MILLENNIUM PHARM INC24 citations92
US6509346B2Jan 21, 2003
Chemokine receptor antagonists and methods of use therefor
MILLENNIUM PHARM INC22 citations92
US6503926B2Jan 7, 2003
Chemokine receptor antagonists and methods of use therefor
MILLENNIUM PHARM INC24 citations92
US6433165B1Aug 13, 2002
Chemokine receptor antagonists and methods of use therefor
MILLENNIUM PHARM INC28 citations92
US6329385B1Dec 11, 2001
Chemokine receptor antagonists and methods of use therefor
MILLENNIUM PHARM INC38 citations92
US6288084B1Sep 11, 2001
Chemokine receptor antagonists and methods of use therefor
MILLENNIUM PHARM INC41 citations92
US6288083B1Sep 11, 2001
Chemokine receptor antagonists and methods of use therefor
MILLENNIUM PHARM INC44 citations92
US6548499B1Apr 15, 2003
Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
MILLENNIUM PHARM INC24 citations91
US6469002B1Oct 22, 2002
Imidazolidine compounds
MILLENNIUM PHARM INC23 citations90
US7541365B2Jun 2, 2009
Chemokine receptor antagonists and methods of use therefor
MILLENNIUM PHARM INC6 citations73
LULY JAY R
1 patentENANTA PHARM INC
1 patent(unassigned)
1 patentKYOWA HAKKO KOGYO KK
1 patentShowing the top 50 of 59 patents by PatentIndex Score.